These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 688286)

  • 21. Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
    Lynch G; Currie V; Kemeny N
    Cancer Clin Trials; 1981; 4(3):281-3. PubMed ID: 6974612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma.
    Paul AR; Catalano RB; Engstrom PF
    Cancer Treat Rep; 1980; 64(10-11):1047-9. PubMed ID: 7006805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil combined with high-dose folinic acid. An update.
    Machover D; Goldschmidt E; Schwarzenberg L; Vanden-Bulcke JM; Misset JL; Chollet P; Mathé G
    Chemioterapia; 1985 Oct; 4(5):369-76. PubMed ID: 3878231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
    Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
    Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.
    Perry MC; Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Treat Rep; 1976 Sep; 60(9):1247-50. PubMed ID: 797447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
    Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma.
    Dy C; Gil A; Algarra SM; Aparicio LA; Calvo F; Herranz P
    Cancer Treat Rep; 1986 Apr; 70(4):465-8. PubMed ID: 3698039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
    Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
    Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
    Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
    Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
    Natoli C; Scognamiglio MT; Martino MT; Irtelli L; De Tursi M; Cianchetti E; Mascitelli E; Tinari N; Iacobelli S
    Anticancer Res; 2000; 20(2B):1253-6. PubMed ID: 10810430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny NE; Gralla RJ
    Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II study of metronidazole therapy for advanced colorectal carcinoma.
    Frytak S; Moertel CG; Childs DS; Schutt AJ; Albers JW
    Cancer Treat Rep; 1978 Mar; 62(3):483-5. PubMed ID: 348320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of advanced colorectal cancer with a combination of 5-fluorouracil and methyl-CCNU.
    Fischetti MR; Carey RW; Weitzman SA; Kaufman S; Kelley RM; Sohier WD
    Med Pediatr Oncol; 1978; 4(3):277-8. PubMed ID: 683130
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
    Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
    Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275).
    Douglass HO; Lavin PT; Evans JT; Mittelman A; Carbone PP
    Cancer Treat Rep; 1979 Aug; 63(8):1355-7. PubMed ID: 476709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential 5-fluorouracil and hydroxyurea therapy for metastatic colorectal adenocarcinoma.
    Krein BM; Conroy JF; Brodsky I
    J Am Osteopath Assoc; 1978 Apr; 77(8):604-5. PubMed ID: 649446
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
    O'Connell MJ; Shani A; Rubin J; Moertel CG
    Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.